• Report SKU:SKU: HVR3397
  • Description
  • Table of Contents
  • Request Sample

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2016 to 2027 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities. This report provides: ●  Market Sizing estimations and forecasts across the given market segments ●  Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, ) ●  Strategic recommendations in key business segments based on the market estimations ●  Regional and country level market analysis ●  Competitive landscaping of major market players ●  Company profiling covering the financials, recent activities and the future strategies

1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research Sources
1.4.2 Primary Research Sources
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Virology Market by Product
5.1 Introduction
5.2 Interferons
5.2.1 Cytokines
5.3 Antiviral Chemotherapy
5.3.1 Antiviral Agents
5.3.2 Immunomodulators
5.3.3 Veridical Agents
5.4 Viral Infection Controlling Method:
5.4.1 Active Prophylaxis
5.4.2 Immunoprophylaxis
5.4.3 Passive Prophylaxis
5.5 Diagnosing Test
5.5.1 DNA Viruses
5.5.2 Hepatitis B
5.5.3 Hepatitis C
5.5.4 Human Immunodeficiency Virus (HIV)
5.5.5 Human Papilloma Virus (HPV)
5.5.6 Prions Diagnostic Test
5.5.7 RNA Viruses
5.5.8 Other Diagnosing Tests
5.5.8.1 Dengue
5.5.8.2 Ebola
5.5.8.3 Influenza

6 Virology Market by Application
6.1 Introduction
6.2 CNS Infections
6.3 Eye Infections
6.4 GI Tract Infections
6.5 Perinatal Infections
6.6 Respiratory Tract Infections
6.7 Sexually Transmitted Diseases
6.8 Skin and Soft Tissue Infections
6.9 Urinary Tract Infection

7 Virology Market by End User
7.1 Introduction
7.2 Blood Banks
7.3 Clinics
7.4 Diagnostic Centers
7.5 Hospitals
7.6 Laboratories
7.7 Pharmacies
7.8 Research & Academic Institutions

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Argentina
8.4.2 Brazil
8.4.3 Venezuela
8.4.4 Chile
8.4.5 Peru
8.5 Middle East & Africa
8.5.1 UAE
8.5.2 Saudi Arabia
8.5.3 Qatar
8.5.4 Iran
8.5.5 South Africa
8.5.6 Rest of Middle East & Africa

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Abbott Laboratories
10.2 AbbVie Inc
10.3 Abivax SA
10.4 AstraZeneca PLC
10.5 Boehringer Ingelheim Corporation
10.6 Fritz Hoffmann-La Roche
10.7 GlaxoSmithKline plc
10.8 Johnson & Johnson
10.9 Merck KGaA
10.10 Novartis AG

11 Appendix

12 Disclaimer

List of Tables
Table 1 Global Virology Market Analysis, by Region, (2017-2027) ($MN)
Table 2 Global Virology Market Analysis, by Product, (2017-2027) ($MN)
Table 3 Global Virology Market Analysis, by Interferons, (2017-2027) ($MN)
Table 4 Global Virology Market Analysis, by Cytokines, (2017-2027) ($MN)
Table 5 Global Virology Market Analysis, by Antiviral Chemotherapy, (2017-2027) ($MN)
Table 6 Global Virology Market Analysis, by Antiviral Agents, (2017-2027) ($MN)
Table 7 Global Virology Market Analysis, by Immunomodulators, (2017-2027) ($MN)
Table 8 Global Virology Market Analysis, by Veridical Agents, (2017-2027) ($MN)
Table 9 Global Virology Market Analysis, by Viral Infection Controlling Method:, (2017-2027) ($MN)
Table 10 Global Virology Market Analysis, by Active Prophylaxis, (2017-2027) ($MN)
Table 11 Global Virology Market Analysis, by Immunoprophylaxis, (2017-2027) ($MN)
Table 12 Global Virology Market Analysis, by Passive Prophylaxis, (2017-2027) ($MN)
Table 13 Global Virology Market Analysis, by Diagnosing Test, (2017-2027) ($MN)
Table 14 Global Virology Market Analysis, by DNA Viruses, (2017-2027) ($MN)
Table 15 Global Virology Market Analysis, by Hepatitis B, (2017-2027) ($MN)
Table 16 Global Virology Market Analysis, by Hepatitis C, (2017-2027) ($MN)
Table 17 Global Virology Market Analysis, by Human Immunodeficiency Virus (HIV), (2017-2027) ($MN)
Table 18 Global Virology Market Analysis, by Human Papilloma Virus (HPV), (2017-2027) ($MN)
Table 19 Global Virology Market Analysis, by Prions Diagnostic Test, (2017-2027) ($MN)
Table 20 Global Virology Market Analysis, by RNA Viruses, (2017-2027) ($MN)
Table 21 Global Virology Market Analysis, by Other Diagnosing Tests, (2017-2027) ($MN)
Table 22 Global Virology Market Analysis, by Application, (2017-2027) ($MN)
Table 23 Global Virology Market Analysis, by CNS Infections, (2017-2027) ($MN)
Table 24 Global Virology Market Analysis, by Eye Infections, (2017-2027) ($MN)
Table 25 Global Virology Market Analysis, by GI Tract Infections, (2017-2027) ($MN)
Table 26 Global Virology Market Analysis, by Perinatal Infections, (2017-2027) ($MN)
Table 27 Global Virology Market Analysis, by Respiratory Tract Infections, (2017-2027) ($MN)
Table 28 Global Virology Market Analysis, by Sexually Transmitted Diseases, (2017-2027) ($MN)
Table 29 Global Virology Market Analysis, by Skin and Soft Tissue Infections, (2017-2027) ($MN)
Table 30 Global Virology Market Analysis, by Urinary Tract Infection, (2017-2027) ($MN)
Table 31 Global Virology Market Analysis, by End User, (2017-2027) ($MN)
Table 32 Global Virology Market Analysis, by Blood Banks, (2017-2027) ($MN)
Table 33 Global Virology Market Analysis, by Clinics, (2017-2027) ($MN)
Table 34 Global Virology Market Analysis, by Diagnostic Centers, (2017-2027) ($MN)
Table 35 Global Virology Market Analysis, by Hospitals, (2017-2027) ($MN)
Table 36 Global Virology Market Analysis, by Laboratories, (2017-2027) ($MN)
Table 37 Global Virology Market Analysis, by Pharmacies, (2017-2027) ($MN)
Table 38 Global Virology Market Analysis, by Research & Academic Institutions, (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.